One of our preclinical companies is currently looking for an experienced biopharma entrepreneurial-minded CEO.
The company specializes in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation, with two lead candidates under development. The team is seeking an individual with a strong network in Venture Capital and a demonstrable track record in fundraising, ideally with a background in biopharma R&D, business development, or venture capital.
To get in touch, please send an email to virginia.ballotta@baselaunch.ch.
